Drawing for CHD PHARMACY

USPTO serial 88205246

CHD PHARMACY

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
BUTLER, ANDREA P
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with CHD PHARMACY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Arkadia Olson

Arkadia Olson EXPRESS SCRIPTS STRATEGIC DEVELOPMENT, IOne Express Way, HQ2-E03ST. LOUIS, MO 63121UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
035mail order pharmacy services; central fill pharmacy services, namely, processing online and telephone prescription orders in retail and central fill pharmacies; pharmaceutical cost management services and drug utilization review; business consulting and management advice services in the field of pharmacy filling; providing business management advice in the field of pharmacy home deliveryACTIVE—
039providing pharmacy home delivery consulting adviceACTIVE—
044medical services, namely, providing information to patients in the fields of health and administering medications; preparation and dispensing of medications; medical counseling in the nature of drug therapy counseling and disease management counseling; medical and health information services, namely, providing medical and health information and advice for patients and physicians regarding diseases, treatment regimens, management of medical conditions, clinical assessment of medical conditions, minimization of the overutilization of drugs; providing a website featuring medical information relating to prescription drugs; and pharmacists' services to make up prescriptions and dissemination of information provided therewithACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Aug 1, 2022MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Aug 1, 2022ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Dec 8, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 7, 2021EX5GSOU EXTENSION 5 GRANTED—
Dec 7, 2021AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Nov 30, 2021EXT5SOU EXTENSION 5 FILED—
Nov 30, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 10, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 8, 2021EX4GSOU EXTENSION 4 GRANTED—
Jun 8, 2021EXT4SOU EXTENSION 4 FILED—
Jun 8, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 21, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 19, 2020EX3GSOU EXTENSION 3 GRANTED—
Nov 19, 2020EXT3SOU EXTENSION 3 FILED—
Nov 19, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 15, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 13, 2020EX2GSOU EXTENSION 2 GRANTED—
May 13, 2020EXT2SOU EXTENSION 2 FILED—
May 13, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 28, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 26, 2019EX1GSOU EXTENSION 1 GRANTED—
Nov 26, 2019EXT1SOU EXTENSION 1 FILED—
Nov 26, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 25, 2019NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 30, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 30, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 10, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 26, 2019PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Mar 23, 2019ALIEASSIGNED TO LIE—
Mar 4, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 4, 2019XAECEXAMINER'S AMENDMENT ENTERED—
Mar 4, 2019GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Mar 4, 2019GNEAEXAMINERS AMENDMENT E-MAILED—
Mar 4, 2019CNEAEXAMINERS AMENDMENT -WRITTEN—
Feb 26, 2019DOCKASSIGNED TO EXAMINER—
Dec 13, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 29, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance